An observational study in Necrosis, sponsored by Methodist Health System. Status unknown at 1 site in United States. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2022-02-04.
Sponsored by Methodist Health System · Observational
Primary Objective:
The primary objective of this study is to develop and validate a clinical risk index score for identifying NSTIs in emergency general surgery patients being evaluated for a severe skin and soft tissue infection.
Secondary Objectives:
To describe the contemporary microbiology of NSTIs and explore the effects on outcomes and to identify predictors of amputation and mortality.
This study is designed as a multicenter, prospective, observational study. There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center. We plan to complete the data collection and analysis by 12/30/2021.
90 studies on the registry are indexed under Soft Tissue Infections; 11 are open to participants now.
This study's planned enrollment of 1,010 is above the median of 300 across 28 observational studies indexed under Soft Tissue Infections.
Browse Soft Tissue Infections studies →Methodist Health System is the lead sponsor of 169 studies on the registry; 52 are open to participants now.
Counted across the registry records on this site, refreshed daily.
study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center.
Exclusion Criteria:
There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center.
Change in the presence of necrosis
presence of necrosis-"dishwater" fluid or deliquescent tissues
Time frame: up to 30 days
Change in the presence of necrosis
thrombosed vessels or absence of bleeding
Time frame: up to 30 days
mortality length of time in hospital
Time frame: 30-90 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Methodist Health System